On track to initiate Ph1/2a trial for ABS-201 (anti-PRLR for androgenetic alopecia) in December; hosting KOL seminar on December 11 Expanding ABS-201 strategy to pursue endometriosis as additional ...
Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a clinical-stage biotechnology company focused on the development of high-purity, pathogen-specific bacteriophage ...
The court released missing exhibits from Delphi murderer Richard Allen's case, signaling that Allen's appeal is about 30 days from filing.
FrontView REIT, Inc. (the "Company", "FrontView", "we", "our", or "us"), today announced its operating results for the quarter ended September 30, 2025. MANAGEMENT COMMENTARY Stephen Preston, CEO and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback